Revvity edges higher with a clear analyst consensus, shares backed by Buy ratings
23.06.2026 - 20:07:06 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:06.
Revvity Inc. (US76155R1086) sits in a defined analyst landscape today. The NYSE-listed healthcare stock trades in a range between roughly 94 and 105 dollars, while 11 Wall Street analysts assign a consensus Buy rating as of June 23, 2026.Analyst consensus data on Public.com
What analysts are signaling
The latest overview from Public.com shows 11 analysts covering Revvity Inc., with an overall Buy consensus on the shares as of June 23, 2026.Consensus breakdown for RVTY Around 18 percent of these analysts rate the stock Strong Buy, 27 percent recommend Buy and 55 percent suggest Holding the shares.Rating distribution for Revvity
Financial analysts on the same platform report an average price target of 107.45 dollars for Revvity, close to the current trading zone.Price target snapshot The data underlines a cautious upside view, with expectations updated regularly around earnings and sector developments.
How the shares trade on NYSE
TradingKey data place Revvity shares at about 100.54 dollars during US market hours, with the stock moving 1.51 percent higher on the day in the latest snapshot.Recent technical overview on TradingKey The same technical read notes a current price momentum score of 7.00, ranking the company 81st out of 203 names in the Healthcare Equipment & Supplies industry.Momentum and industry ranking
According to this technical analysis, Revvity shares are trading between a resistance level at 105.26 dollars and support at 93.77 dollars.Support and resistance levels The indicators currently show more sell than buy signals, pointing to a range-bound configuration rather than a clear trend.
Further news and data on the Revvity shares
For more background, ad hoc releases and additional market data on Revvity, the topic page and the company’s own investor relations site offer a broader picture.
The business behind the ticker
Revvity, formerly known as PerkinElmer, positions itself as a global life sciences and diagnostics company. It supplies instruments, reagents and software used for drug discovery and clinical testing, serving pharmaceutical, biotech and healthcare customers worldwide.Business overview for Revvity
Where the shares trade today
The Revvity shares (US76155R1086) trade on the NYSE at around 100.54 dollars as of 2026-06-23, 19:54 Eastern Time, based on recent technical and quote data. The company’s market capitalization stands near 11.29 billion dollars in the latest snapshot.Latest price and market cap
Key data on the Revvity shares
- Company: Revvity Inc.
- ISIN: US76155R1086
- WKN: not available
- Ticker: RVTY
- Trading venue: NYSE
- Price (as of 2026-06-23, 19:54): 100.54 USD
- Market cap: 11.29 billion USD (as of 2026-06-23)
- Sector / industry: Healthcare equipment & supplies, life sciences tools
- Index membership: not in S&P 500 or NASDAQ-100 based on latest public listings
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice, tax advice or a solicitation to buy or sell securities. Figures and assessments are based on publicly available sources at the time of review and may change without notice.
